Adjuvant Gemcitabine-Oxaliplatin (GEMOX) after Curative Surgery in High-risk Patients with Cholangiocarcinoma

BACKGROUND: There is no standard adjuvant chemotherapy to prevent recurrent cholangiocarcinoma (CCA), a rare cancer with poor prognosis. We assessed the efficacy and safety of GEMOX on intrahepatic and hilar CCA with high-risk factors after curative surgery. PATIENTS AND METHODS: Twenty two patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Paule, Bernard, Andreani, Paola, Bralet, Marie-Pierre, Guettier, Catherine, Adam, René, Castaing, Denis, Azoulay, Daniel
Formato: Texto
Lenguaje:English
Publicado: Libertas Academica 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2872598/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2872598/

Ejemplares similares